Gi‐Ae Kim

HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

Gi‐Ae Kim, Young‐Suk Lim, Jihyun An et al. · Gut · 2013 · 418 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Association between non-alcoholic fatty liver disease and cancer incidence rate

Gi‐Ae Kim, Han Chu Lee, Jaewon Choe et al. · Journal of Hepatology · 2017 · 339 citations

Medicine, Oncology, Cancer Epidemiology +12

High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B

Gi‐Ae Kim, Young‐Suk Lim, Seungbong Han et al. · Gut · 2017 · 258 citations

Medicine, Immunology, Clinical Immunology +16

Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early‐Stage Hepatocellular Carcinoma

Jonggi Choi, Gi‐Ae Kim, Seungbong Han et al. · Hepatology · 2018 · 206 citations

Medicine, Oncology, Cancer Screening +16

Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance

Gi‐Ae Kim, Han Chu Lee, Min-Ju Kim et al. · Journal of Hepatology · 2014 · 144 citations

Medicine, Internal Medicine, Oncology +16